Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
ONNVF
)
1.430
UNCHANGED
Last Price
Updated: 1:52 PM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.430
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.430
Today's Range
1.430 - 1.430
52wk Range
0.8000 - 3.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
July 31, 2025
Reduce development timelines and costs, while improving access to life-saving treatments
From
OneMedNet Corporation
Via
GlobeNewswire
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
July 30, 2025
Via
ACCESS Newswire
Performance
YTD
+2.9%
+2.9%
1 Month
N/A
N/A
3 Month
+78.7%
+78.7%
6 Month
+2.9%
+2.9%
1 Year
+2.9%
+2.9%
More News
Read More
Onco-Innovations Announces Private Placement
July 29, 2025
Via
ACCESS Newswire
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
July 21, 2025
Via
ACCESS Newswire
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
July 11, 2025
Via
ACCESS Newswire
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
July 10, 2025
Via
ACCESS Newswire
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
July 04, 2025
Via
ACCESS Newswire
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
July 02, 2025
Via
ACCESS Newswire
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
June 27, 2025
Via
ACCESS Newswire
Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
June 25, 2025
Via
ACCESS Newswire
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
June 20, 2025
Via
ACCESS Newswire
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
June 13, 2025
Via
ACCESS Newswire
Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
June 05, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
May 26, 2025
Via
ACCESS Newswire
Onco-Innovations Extends Marketing Program
May 26, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
May 22, 2025
Via
ACCESS Newswire
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
May 16, 2025
Via
ACCESS Newswire
Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
April 24, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
April 17, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Private Placement
April 16, 2025
Via
ACCESS Newswire
Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
April 10, 2025
Via
ACCESS Newswire
Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
April 03, 2025
Via
ACCESS Newswire
Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
March 26, 2025
Via
ACCESS Newswire
Onco-Innovations Extends Marketing Program
March 25, 2025
Via
ACCESS Newswire
Onco-Innovations Provides Update on Use of Proceeds
March 24, 2025
Via
ACCESS Newswire
Frequently Asked Questions
Is ONNVF publicly traded?
Yes, ONNVF is publicly traded.
What exchange does ONNVF trade on?
ONNVF trades on the OTC Traded
What is the ticker symbol for ONNVF?
The ticker symbol for ONNVF is ONNVF on the OTC Traded
What is the current price of ONNVF?
The current price of ONNVF is 1.430
When was ONNVF last traded?
The last trade of ONNVF was at 07/10/25 01:52 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.